2655. Phase 1 Safety and Immunogenicity Results of Two Investigational mRNA Vaccines, mRNA-1345, a Respiratory Syncytial Virus Vaccine, and mRNA-1653, a Human Metapneumovirus and Parainfluenza Virus Type 3 Combination Vaccine in Seropositive Young Children

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10677146 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature